rxstat › Shortages › Quetiapine

Quetiapine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Quetiapine products are in shortage in Canada (47 of 117 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.
Products affected
47 / 117
In shortage since
Apr 1, 2017
Est. full return
Dec 31, 2026
Reports on file
317
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-QUETIAPINE XR
200MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02395460 · since Jan 8, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-QUETIAPINE XR
300MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02395479 · since Aug 19, 2025, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-QUETIAPINE XR
400MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02395487 · since Sep 2, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACT QUETIAPINE
300MG · TABLET · TEVA CANADA LIMITED
DIN 02316129 · since May 5, 2026, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-QUETIAPINE XR
50MG · TABLET (EXTENDED-RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522187 · since Jan 18, 2024, est. end Apr 30, 2025 · Disruption of the manufacture of the drug.
Active shortage
TEVA-QUETIAPINE XR
50MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02395444 · since May 1, 2025, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-QUETIAPINE XR
150MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02395452 · since Jan 14, 2026, est. end Aug 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-QUETIAPINE XR
400MG · TABLET (EXTENDED-RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522225 · since Jan 18, 2024, est. end Aug 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
MINT-QUETIAPINE XR
150MG · TABLET (EXTENDED-RELEASE) · MINT PHARMACEUTICALS INC
DIN 02522195 · since Jan 18, 2024, est. end Aug 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
QUETIAPINE XR
50MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02519607 · since Jan 19, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
QUETIAPINE XR
300MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02519747 · since Jan 19, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
QUETIAPINE XR
400MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02519763 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Quetiapine is currently affected by 47 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, MINT PHARMACEUTICALS INC, JAMP PHARMA CORPORATION, NORA PHARMA INC and 5 others.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; other (please describe in comments); delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Quetiapine is classified under “ANTIPSYCHOTICS” (ATC N05AH).

Recent changes

Common questions

When will Quetiapine be back in stock in Canada?

The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Quetiapine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antipsychotics)

Widespread shortagePericiazine2 of 4 reported products affectedWidespread shortageTrifluoperazine5 of 5 reported products affectedPartial shortageAripiprazole3 of 29 reported products affected · est. return Jul 17, 2026Partial shortageFluphenazine1 of 2 reported products affected · est. return Jun 5, 2026Partial shortageHaloperidol6 of 16 reported products affected · est. return Jul 10, 2026Partial shortageLithium Carbonate4 of 11 reported products affected · est. return Jan 1, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.